Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

被引：8
|
作者：
Burke, Michael J. [1 ,2 ]
Ziegler, David S. [3 ]
Bautista Sirvent, Francisco Jose [4 ]
Attarbaschi, Andishe [5 ,6 ]
Gore, Lia [7 ]
Locatelli, Franco [8 ]
O'Brien, Maureen M. [9 ]
Pauly, Melinda [10 ]
Obreja, Mihaela [11 ]
Morris, Christopher L. [11 ]
Baruchel, Andre [12 ,13 ]
机构：
[1] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
[2] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[3] Sydney Childrens Hosp, Randwick, NSW, Australia
[4] Hosp Nino Jesus, Serv Oncol Pediat, Madrid, Spain
[5] St Anna Childrens Hosp, Vienna, Austria
[6] Childrens Canc Res Inst, Vienna, Austria
[7] Univ Colorado, Childrens Hosp Colorado, Peds Heme Onc BMT CT, Aurora, CO USA
[8] IRCCS Bambino Gesu Childrens Hosp, Dept Pediat Hematol Oncol Cell & Gene Therapy, Rome, Italy
[9] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA
[10] Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA
[11] Amgen Inc, Thousand Oaks, CA USA
[12] Hop Univ Robert Debre, Serv Hematol & Oncol Pediat, AP HP, Paris, France
[13] Univ Paris Dider, Paris, France
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-127350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3873
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
    Burke, Michael J.
    Ziegler, David S.
    Bautista, Francisco
    Attarbaschi, Andishe
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Pauly, Melinda
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2021, 138
  • [2] Phase 1b study of carfilzomib with induction chemotherapy in pediatric relapsed/refractory acute lymphoblastic leukemia
    Burke, Michael J.
    Ziegler, David S.
    Bautista, Francisco
    Attarbaschi, Andishe
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Pauly, Melinda
    Kormany, William N.
    Tian, Shengqi
    Morris, Christopher L.
    Baruchel, Andre
    PEDIATRIC BLOOD & CANCER, 2022, 69 (12)
  • [3] Phase 2 Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
    Ziegler, David S.
    Huynh, Van
    Burke, Michael J.
    Gore, Lia
    Locatelli, Franco
    O'Brien, Maureen M.
    Kim, Christopher
    Obreja, Mihaela
    Morris, Christopher L.
    Baruchel, Andre
    BLOOD, 2021, 138
  • [4] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
    Miyagawa, Naoyuki
    Goto, Hiroaki
    Ogawa, Atsushi
    Kikuta, Atsushi
    Kosaka, Yoshiyuki
    Sekimizu, Masahiro
    Tomizawa, Daisuke
    Toyoda, Hidemi
    Hiramatsu, Hidefumi
    Hara, Junichi
    Mochizuki, Shinji
    Nakayama, Hideki
    Yoshimura, Kenichi
    Iijima-Yamashita, Yuka
    Sanada, Masashi
    Ogawa, Chitose
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 267 - 276
  • [5] Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia
    Naoyuki Miyagawa
    Hiroaki Goto
    Atsushi Ogawa
    Atsushi Kikuta
    Yoshiyuki Kosaka
    Masahiro Sekimizu
    Daisuke Tomizawa
    Hidemi Toyoda
    Hidefumi Hiramatsu
    Junichi Hara
    Shinji Mochizuki
    Hideki Nakayama
    Kenichi Yoshimura
    Yuka Iijima-Yamashita
    Masashi Sanada
    Chitose Ogawa
    International Journal of Hematology, 2023, 118 : 267 - 276
  • [6] A Phase 1B Study of Blinatumomab in Japanese Children with Relapsed/Refractory (R/R) B-Precursor Acute Lymphoblastic Leukemia (ALL)
    Horibe, K.
    Morris, J.
    Tuglus, C.
    Zhu, M.
    Goto, H.
    Ogawa, C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S121 - S121
  • [7] A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Hawkins, Emily
    Fletcher, Theresa
    Allen, Melissa
    Cashen, Amanda F.
    DiPersio, John F.
    Jacoby, Meagan
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    BLOOD, 2014, 124 (21)
  • [8] A phase I study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Fletcher, Theresa
    Hawkins, Emily R.
    Cashen, Amanda
    DiPersio, John F.
    Jacoby, Meagan A.
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 728 - 730
  • [9] A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Horibe, Keizo
    Morris, Joan D.
    Tuglus, Catherine A.
    Dos Santos, Cedric
    Kalabus, James
    Anderson, Abraham
    Goto, Hiroaki
    Ogawa, Chitose
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 223 - 233
  • [10] A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Keizo Horibe
    Joan D. Morris
    Catherine A. Tuglus
    Cedric Dos Santos
    James Kalabus
    Abraham Anderson
    Hiroaki Goto
    Chitose Ogawa
    International Journal of Hematology, 2020, 112 : 223 - 233
12345